Literature DB >> 30072550

Health concerns associated with travelling with inflammatory bowel disease (IBD): a questionnaire survey.

Varun Philip1, Anet Soubieres2, Andrew Poullis2.   

Abstract

When travelling, patients with inflammatory bowel disease (IBD) have a higher risk of morbidity. We identified barriers to travel, specific health concerns and several areas for service improvement among patients. In total, 136 patients were given a 32-question service improvement questionnaire. Of these, 89% travelled abroad, 30% reported that IBD limited travel and 40% said it affected choice of destination. Fourty-seven percent of patients travelled abroad without health insurance and 7% were refused. Seventy-eight percent wanted pre-travel advice from doctors in the future. Popular service improvement options included providing written prescriptions (91%) and management plans (75%). Sixty-three percent of patients were unaware of needing to avoid live vaccines while on immunosuppressants. Ninety-two percent were unaware that high altitudes could precipitate flares; 27% travelled abroad to high-altitude destinations, of which 46% subsequently had flare-ups. Existing IBD travel services remain unknown such as the 'Can't wait' card (72%) and 'IBD passport' (96%). Service improvements in the IBD clinic need to be implemented to facilitate safer travel overseas. © Royal College of Physicians 2018. All rights reserved.

Entities:  

Keywords:  Inflammatory bowel disease; health concerns; immunosuppression; service improvement; travelling

Mesh:

Year:  2018        PMID: 30072550      PMCID: PMC6334055          DOI: 10.7861/clinmedicine.18-4-288

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  9 in total

Review 1.  Psychological stress in IBD: new insights into pathogenic and therapeutic implications.

Authors:  J E Mawdsley; D S Rampton
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

2.  High altitude journeys and flights are associated with an increased risk of flares in inflammatory bowel disease patients.

Authors:  Stephan R Vavricka; Gerhard Rogler; Sandra Maetzler; Benjamin Misselwitz; Ekaterina Safroneeva; Pascal Frei; Christine N Manser; Luc Biedermann; Michael Fried; Peter Higgins; Kacper A Wojtal; Alain M Schoepfer
Journal:  J Crohns Colitis       Date:  2013-08-13       Impact factor: 9.071

3.  Vaccination issues in patients with inflammatory bowel disease receiving immunosuppression.

Authors:  Seper Dezfoli; Gil Y Melmed
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-08

4.  Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.

Authors:  J F Rahier; F Magro; C Abreu; A Armuzzi; S Ben-Horin; Y Chowers; M Cottone; L de Ridder; G Doherty; R Ehehalt; M Esteve; K Katsanos; C W Lees; E Macmahon; T Moreels; W Reinisch; H Tilg; L Tremblay; G Veereman-Wauters; N Viget; Y Yazdanpanah; R Eliakim; J F Colombel
Journal:  J Crohns Colitis       Date:  2014-03-06       Impact factor: 9.071

5.  Travel-associated health risks for patients with inflammatory bowel disease.

Authors:  Shomron Ben-Horin; Yoram Bujanover; Shulamit Goldstein; Moshe Nadler; Alon Lang; Uri Kopylov; Lior Katz; Adi Lahat; Eli Schwartz; Benjamin Avidan
Journal:  Clin Gastroenterol Hepatol       Date:  2011-11-02       Impact factor: 11.382

6.  Travel health and pretravel preparation in the patient with inflammatory bowel disease.

Authors:  Kay Greveson; Thomas Shepherd; John P Mulligan; Mark Hamilton; Sue Woodward; Christine Norton; Charles Murray
Journal:  Frontline Gastroenterol       Date:  2015-04-22

7.  Insurance problems among inflammatory bowel disease patients: results of a Dutch population based study.

Authors:  M G V M Russel; B M Ryan; P C Dagnelie; M de Rooij; J Sijbrandij; A Feleus; M Hesselink; J W Muris; R Stockbrugger
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

8.  Vaccinating Patients With Inflammatory Bowel Disease.

Authors:  Jason Reich; Sharmeel Wasan; Francis A Farraye
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-09

Review 9.  Vaccinations in patients with immune-mediated inflammatory diseases.

Authors:  Jean-François Rahier; Michel Moutschen; Alfons Van Gompel; Marc Van Ranst; Edouard Louis; Siegfried Segaert; Pierre Masson; Filip De Keyser
Journal:  Rheumatology (Oxford)       Date:  2010-06-29       Impact factor: 7.580

  9 in total
  3 in total

1.  The past, the present, and the future: reflecting on -medical history as we welcome new leaders.

Authors:  Ed Nicol
Journal:  Clin Med (Lond)       Date:  2018-08       Impact factor: 2.659

2.  Inflammatory Bowel Disease Self-Management: Exploring Adolescent Use of an Online Instagram Support Community.

Authors:  Caeli Malloy; Susan M Rawl; Wendy R Miller
Journal:  Gastroenterol Nurs       Date:  2022-07-13       Impact factor: 1.159

3.  Clinical factors to predict flare-up in patients with inflammatory bowel disease during international air travel: A prospective study.

Authors:  Jihye Park; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim; Dong Ho Lee
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.